Clinical Research Directory
Browse clinical research sites, groups, and studies.
Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)
Sponsor: Technische Universität Dresden
Summary
The study PROSa+ aims to assess patient-reported outcomes (PROs), patient-reported experiences (PREs), and the socioeconomic situation of long-term sarcoma survivors (≥ 5 years post-diagnosis, with or without active disease) in Germany. The mixed-methods research design includes a multicenter observational study with a cross-sectional questionnaire survey involving 1,600 participants (paper, online), qualitative interviews with up to 60 participants, and longitudinal analyses combining data from existing sarcoma registries and the previous PROSa study conducted between 2017 and 2020.
Official title: Understanding Long-Term Sarcoma Survivorship: Risk Profiles, Outcomes and Unmet Needs - A Joint Project of Research, Sarcoma Centres and Patient Experts (PROSa+)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1600
Start Date
2025-11-28
Completion Date
2027-09
Last Updated
2025-12-08
Healthy Volunteers
No
Interventions
No intervention (observational study)
No intervention (observational study)
Locations (5)
Technical University Dresden
Dresden, Saxony, Germany
University Hospital Essen
Essen, Germany
NCT Heidelberg
Heidelberg, Germany
Sarcoma Center Mannheim
Mannheim, Germany
Deutsche Sarkom-Stiftung
Wölfersheim, Germany